AVANIR Pharmaceuticals (NASDAQ:AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Recs

0
Player Avatar Fiskhus (72.87) Submitted: 12/7/2011 1:57:22 PM : Outperform Start Price: $2.53 AVNR Score: +7.80

recycle -30

Report this Post Reply

Featured Broker Partners


Advertisement